News

The company said that its new facility provides 50% and 100% greater manufacturing capacity, respectively, than its existing facility. Robin Smith, chairman and CEO of NeoStem, said: “This

The company said that the protocol provides a simple, three-step testing algorithm that can be customized based upon a patient’s symptoms and history. Step one provides a screen

The collaborative sites are expected to provide clinical expertise and samples to evaluate the clinical utility of a microRNA (miRNA) test, based on FNA biopsies, to distinguish pancreatic

The company said that the researchers are expected to conduct gene expression research in the areas of advanced lung disease and asthma and will use the SmartChip system

CS-8958 is a laninamivir prodrug that is a Long-Acting Neuraminidase Inhibitor. The drug, developed entirely for the Japanese market by Daiichi Sankyo, will be in the form of

Infosys said that Elan and its research partners could realize gains in research productivity by focused and efficient selection of candidate drugs or biologics with the new RISe.

The Ramsell 340B solution combines pharmacy management services such as claims adjudication and utilization reporting, along with a platform that provides specific features to manage and track 340B

The company claims that ELN provides numerous benefits beyond eliminating paper lab notebooks. The open architecture is designed to simplify and accelerate the R&D process by streamlining data

As per the agreement, Cordis will receive $1.725 billion from Boston Scientific and Johnson & Johnson expects to record the majority of this payment as a special item